The company will present at conferences focused on health investments.
- Nektar Therapeutics will participate in two investor conferences.
- The conferences focus on health investments in the biotech sector.
- Presentations will highlight the company's innovations and developments.
Nektar Therapeutics has announced its participation in two upcoming investor conferences in March. The company aims to engage with healthcare-focused investors during these events, providing insights into its recent innovations and development initiatives. This involvement aligns with Nektar's strategy to attract potential partners and investors interested in the biotech field.
The first conference, the 35th Annual Cowen Health Care Conference, will take place on March 6-8, 2023, in Boston, Massachusetts. Nektar will also attend the Oppenheimer 33rd Annual Healthcare Conference scheduled for March 14-15, 2023. Both conferences serve as platforms for Nektar Therapeutics to enhance visibility among potential stakeholders and discuss its pipeline and future goals in the health investments sector.
